All In MedTech

FDA Clearance Tracker · P130022-S061

Nevro Corp Senza Spinal Cord Stimulation (SCS) System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 30, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 30, 2025

Approved

Time to decision

300 days

Received Sep 3, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P130022-S061
Device name
Nevro Corp Senza Spinal Cord Stimulation (SCS) System
Applicant location
Redwood City, CA
Received
Sep 3, 2024
Decided
Jun 30, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P130022

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

approval for the addition of alternate suppliers to the feedthrough (i.e., Integer Tijuana) and titanium case (i.e., Greatbatch Medical) components of the implantable pulse generator (IPG) used in the Senza SCS System, and approval for minor changes made to the feedthrough to improve manufacturability and yield of this component and additional reference specifications that were added for the titanium case for better manufacturability

Source documents

Other decisions for Nevro Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.